PTC Therapeutics PTCT Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's operating lease right-of-use assets in other assets?
- PTC Therapeutics (PTCT) reported operating lease right-of-use assets in other assets of $76.69M in Q1 2026.
- How has PTC Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- PTC Therapeutics's operating lease right-of-use assets in other assets increased by 33.8% year-over-year, from $57.32M to $76.69M.
- What is the long-term trend for PTC Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), PTC Therapeutics's operating lease right-of-use assets in other assets has grown at a -1.1% compound annual growth rate (CAGR), from $84.41M to $80.05M.